Blood thinner for slow-growing babies in pregnancy
Treatments studied
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tests whether a blood thinner called enoxaparin can improve outcomes for babies who are growing slowly in the womb (intrauterine growth restriction, or IUGR) and who have low amniotic fluid. If you qualify, you may receive enoxaparin injections to see if it helps your baby grow better and reduces risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- You are pregnant with only one baby
- You are at least 28 weeks along in your pregnancy
- You have been diagnosed with both restricted growth (IUGR) and low amniotic fluid (oligohydramnios)
- You do not have certain medical conditions like uncontrolled diabetes, chronic high blood pressure, kidney disease, or a clotting problem
- You are not already taking blood thinners
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
This trial uses an MRI scan to look at placental health in pregnancies where the baby (or one twin) is not growing as expected. The goal is to better understand placental problems and how they may affect baby growth.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study tests whether a blood-thinner medicine (LMWH) can improve outcomes for people carrying a singleton baby with early signs of slow growth. It compares LMWH against standard care to see if treatment helps the baby and pregnancy stay safer.
This study looks at whether genetic testing of the amniotic fluid helps understand why some babies grow slowly after 28 weeks of pregnancy. It reviews past cases to see if the test results were useful for parents and doctors.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
Hear when a new Intrauterine Growth Restriction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.